← Back to all trials
Recruiting
NCT06654752
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Conditions: Cystic Fibrosis
Sex: All
Ages: 3 Years – 18 Years
Healthy volunteers: No
Phase: NA
Enrollment: 430
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center
Location: The Children's Hospital Alabama & University of Alabama at Birmingham Birmingham Alabama
Summary
The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for the management of outpatient pulmonary exacerbations (PEx) in the pediatric CF population.
Eligibility Criteria
Inclusion Criteria:
1. Age
1. For main cohort and non-HEMT cohort: age 6 to \
Source: ClinicalTrials.gov (NCT06654752). StuddyBuddy aggregates publicly available trial information.
